Webinar : Reflections and learnings from the early gene therapies for Hemophilia B

This webinar is organized and funded by CSL Behring GL-HGX-0002.
TUESDAY, AUGUST 26 2025, 18.30 CET / 12:30 EST / 09:30 PST / 20:30 GST Gulf
This 45-minute live webinar traces the evolution of gene therapies in Hemophilia B—from early adeno-associated virus based vectors to key clinical milestones, including recently published 13-year follow-up data. The session will explore the scientific journey and transformative potential of gene transfer in Hemophilia B.

This webinar is intended for physicians and features the involvement of Robert Klamroth and Wolfgang Miesbach, The European Association for Haemophilia and Allied Disorders Past President and Secretary, respectively, and shared with the awareness of the International Society on Thrombosis and Haemostasis. Reflecting a shared commitment to advancing care through scientific dialogue.

Steering committee

Amit Nathwani MD
Department of Hematology, University College London
Frank Leebeek MD
Department of Hematology, Erasmus University Medical Center
Robert Klamroth MD
Department of Internal Medicine and Coagulation Disorders, Vivantes Hospital
Mr. H
Patient with long-term follow-up after gene therapy
Moderator
Wolfgang Miesbach MD
The Haemophilia Center, Frankfurt University Hospital